Genetic testing provides a snapshot of a patient's DNA that can improve the safety and efficacy of a psychiatric treatment plan. Our providers offer pharmacogenetics testing via Genomind® Professional PGx Express™and The GeneSight® Psychotropic Test to tailor psychiatric treatment decisions to a patient's unique genetic make-up. By analyzing a patient's genetic variations we can optimize their response to treatments and minimize the potential for adverse medication reactions.
Included in a pharmacogenetics analysis is detailed information on which medications compliment a patient's neurochemistry, which medications may lead to adverse reactions or treatment failures, how the body processes or "metabolizes" certain medications, and whether there is a predisposition to deficiencies that could contribute to psychiatric symptoms.
Our team will assist in coordinating delivery of a simple at-home cheek swab collection kit, which will provide the genetic material needed for analysis. Results of genetic testing are typically ready for provider interpretation within a week of sample processing. The pharmacogenetics assay report will be interpreted and reviewed with a patient during a 45-minute consultation with one of our prescribing providers. These results will guide development of a more individualized psychiatric treatment plan for new patients and will help optimize current treatment plans for established patients.